https://www.zonebourse.com/cours/action/ZYDUS-LIFESCIENCES-LIMITE-34067618/actualite/Zydus-recoit-l-approbation-finale-de-l-USFDA-pour-le-chlorhydrate-de-chlorpromazine-injectable-USP-46221307/?utm_source=telegram&utm_medium=social&utm_campaign=share